Sort
261,768 grants matching “gene therapy”
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome
$863,379Warren J Manning · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
Heritable Disorders of Connective Tissue
$863,324Joan C Marini · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Cardiovascular Cell Therapy Research Network
$863,317James T. Willerson · Texas Heart Institute · UM1 · FY2012 · HL
Proteomics Core
$863,234S Munir Alam · Duke University · U19 · FY2011 · AI
Depleting autoantibodies for the treatment of autoimmunity
$863,199Sunil Kannanganat Sidharthan · Astero Erado Inc · R44 · FY2025 · AI
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression
$863,194Russell Christian Rockne · Beckman Research Institute/City Of Hope · U01 · FY2022 · CA
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens
$863,175Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$863,153Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
IMPACT OF FARMING ENVIRONMENT ON IMMUNE MATURATION AND RESPIRATORY HEALTH
$863,116James E. Gern · University Of Wisconsin-Madison · U19 · FY2015 · AI
Investigation of lung tumor development and treatment
$863,073Tyler E Jacks · Massachusetts Institute Of Technology · U01 · FY2007 · CA
Cadaveric Donor Lung and Bone Marrow Transplantation in Immunodeficiency Diseases
$863,011Paul Szabolcs · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · AI
Utility of AAV Serotypes for Gene Delivery in Treatment of Chronic Joint Disease
$862,998Steven C Ghivizzani · University Of Florida · R01 · FY2011 · AR
Validating targets in p. aeruginosa type III secretion using chemical probes
$862,926Donald T Moir · Microbiotix, Inc · R01 · FY2012 · AI
Genetic Determinants of Epilepsy in Murine Systems
$862,733Wayne N. Frankel · Columbia University Health Sciences · R37 · FY2019 · NS
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$862,729Damian J. Green · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$862,669Donald L Sodora · Seattle Children'S Hospital · R01 · FY2024 · AI
Mouse Models of FXTAS: Defining Critical Periods and Molecular Targets
$862,653Robert F Berman · University Of California At Davis · RL1 · FY2011 · NS
Understanding the overlap of chromatin alteration in HIV-1 and drug abuse
$862,646Zachary Alan Klase · Drexel University · DP2 · FY2017 · DA
HBI-002 to Treat Delayed Graft Function in Kidney Transplant
$862,618Edward Gomperts · Hillhurst Biopharmaceuticals, Inc. · R44 · FY2016 · DK
Role of B Lymphocytes In HIV Infection And Pathogenesis
$862,591Anthony S. Fauci · Niaid Extramural Activities · Z01 · FY2007 · AI
Systematic Investigation of Protein Ubiquitination in ARDS
$862,581Beibei Chen · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · HL
Leber Hereditary Optic Neuropathy: Gene Therapy Trial
$862,515John R Guy · University Of Miami School Of Medicine · R24 · FY2010 · EY
Neurotology Program
$862,489Wade Chien · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC
Genetic variants that affect the airway epithelium to drive obstructive lung disease
$862,442Yohannes Tesfaigzi · Brigham And Women'S Hospital · R01 · FY2024 · HL
A new humanized mouse model to study HBV gene editing
$862,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2024 · AI